Chuck Triano
Senior Vice President, Investor Relations
Replay available
Bristol-Myers Squibb Company (BMY) Q2 2025 Earnings Call
Bristol-Myers Squibb Company (NYSE: BMY) Q2 2025 earnings conference call, held 2025-07-31. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Chris Berner
Board Chair and Chief Executive Officer
David Elkins
Chief Financial Officer
Jeff Meacham
Analyst, Citibank
Courtney Breen
Analyst, Bernstein
Chris Schott
Analyst, JP Morgan
Evan Sigerman
Analyst, BMO Capital Markets
Louisa Hector
Analyst, Berenberg
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Bristol-myers Squibb Company.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.197 Good day and welcome to the Bristol-Myers Squibb Second Quarter 2025 Earnings Conference 00:00:05.197 -- 00:00:08.660 Call. All participants will be in a listen-only mode. 00:00:08.660 -- 00:00:12.324 Should you need assistance, please signal a conference specialist by pressing the star 00:00:12.324 -- 00:00:14.687 key followed by zero. 00:00:14.687 -- 00:00:19.051 After today's presentation, there will be an opportunity to ask questions. 00:00:19.051 -- 00:00:23.236 To ask a question, you may press star then one on your telephone keypad. 00:00:23.236 -- 00:00:27.220 And to withdraw your question, please press star then two. 00:00:27.220 -- 00:00:31.054 Please note this event is being recorded I would now like to turn the conference over 00:00:31.054 -- 00:00:35.602 to Mr. Chuck Triano, Senior Vice President in Hidden Investor Relations. 00:00:35.602 -- 00:00:37.713 Please go ahead, sir. 00:00:37.713 -- 00:00:41.819 Thank you, and good morning, everyone. We appreciate you joining our second quarter 2025 00:00:41.819 -- 00:00:46.907 earnings call. Joining me this morning with prepared remarks are Chris Berner, our board 00:00:46.907 -- 00:00:51.294 chair and chief executive officer, and David Elkins, our chief financial officer. 00:00:51.294 -- 00:00:56.643 Also participating in today's call are Adam Lemkowski, our chief commercialization officer, 00:00:56.643 -- 00:01:01.540 and Samit Hirawat, our chief medical officer and head of global drug development. 00:01:01.540 -- 00:01:05.908 Earlier this morning, we posted our quarterly slide presentation to BMS.com that you 00:01:05.908 -- 00:01:08.833 can use to follow along with Chris and David's remarks. 00:01:08.833 -- 00:01:12.821 Before we get started, I'll remind everybody that dur...